Since the early 1990's I have been an advocate of using electrodermal activity as an simple objective physiological screening test in ADHD. Althogh I had been using GSR biofeedback for helping ADHD children and students increase focus as well as learn to achieve relaxed concentration in the classroom, there had been more of a focus on EEG biofeedback and neurofeedback for helping ADHD. These methods still remain controversial and expensive as well as time consuming to achieve results. In 2006 , I had released an educational video showing how the GSR could be used to screen for attention difficulties in ADHD - GSR Biofeedback Techniques For The Natural ADHD Practitioner. This data was compiled over a 15 year period helping ADHD students in Israel. Only recently , I have been able to find brain research studies showing a link between ADHD and abnormal or different electro dermal activity in ADHD. The following are links to studies now corroborating a link between electrodermal activity in ADHD, and subsequently support GSR biofeedback as a valid and primary modality in managing ADHD.
Reduced electrodermal response to errors predicts poor sustained attention performance in attention deficit hyperactivity disorder.
AUTONOMIC NERVOUS SYSTEM Neuroreport. 15(16):2535-2538, November 15, 2004.
O'Connell, Redmond G. 1 CA; Bellgrove, Mark A. 1 2; Dockree, Paul M. 1; Robertson, Ian H. 1
Simultaneous EEG and EDA measures in adolescent attention deficit hyperactivity disorder.
Lazzaro I, Gordon E, Li W, Lim CL, Plahn M, Whitmont S, Clarke S, Barry RJ, Dosen A, Meares R.
Event-related brain potentials, bilateral electrodermal activity and Mangina-Test performance in learning disabled/ADHD pre-adolescents with severe behavioral disorders as compared to age-matched normal controls
Constantine A. Mangina, , J. Helen Beuzeron-Mangina and Natalie Grizenko
Montreal Research and Treatment Center and Department of Neuro-Psychophysiology, Division of Child and Adolescent Psychiatry, Douglas Hospital, McGill University, Montreal, Quebec, Canada H3A 2B1
Accepted 29 July 1999. Available online 23 May 2000.
Method for determining attention deficit hyperactivity disorder (ADHD) medication dosage and for monitoring the effects of (ADHD) medication Document Type and Number:United States Patent 6520921 Link to this page:http://www.freepatentsonline.com/6520921.html Abstract:A method for determining the appropriate dosage of a medication to treat Attention Deficit Hyperactivity Disorder (ADHD) in an individual who has ADHD comprising: sampling the peripheral skin temperature of a human subject during a predetermined time interval when the subject is in an inactive state to provide sampled peripheral skin temperature data; analyzing the sampled peripheral skin temperature data for a pre-selected parameter to determine whether the pre-selected parameter has a value indicative of ADHD; and determining the proper dosage of a medication to treat ADHD based upon the determined value of the pre-selected parameter.
